相关实验视频

Updated: Jan 13, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

2000-2024年对肝癌和瘤免疫微环境的干预疗法的文献分析分析

Siqin Liang¹, Ming Li², Zhiliang Xu¹

¹Department of Hepatobiliary Tumor Surgery, Department of Interventional Therapy, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang, China; Jiangxi Key Laboratory of Translational Cancer Research, Jiangxi Cancer Hospital of Nanchang University, Nanchang, China; Gannan Medical University, Ganzhou, China.

Chinese clinical oncology

|January 6, 2026

概括

这项文献计量研究分析了肝癌干预治疗研究,强调瘤免疫微环境 (TIME). 新兴趋势侧重于免疫向抑制和免疫疗法,提供新的研究方向.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
图书统计学图书统计学

背景情况:

瘤免疫微环境 (TIME) 在肝癌干预治疗中越来越重要.
了解TIME动态对于推进治疗策略至关重要.

研究的目的:

在肝癌干预治疗中对瘤免疫微环境 (TIME) 的研究进行文献计量分析.
确定当前的研究热点和该领域未来的发展趋势.

主要方法:

在科学网络 (WOS) 核心集合 (2000-2024) 上进行了全面的文献搜索.
使用VOSviewer,CiteSpace和R"Bibliometrix"软件进行了圣经测量分析.
分析了来自21个地区的277篇文章的数据.

主要成果:

研究产出每年都在增加,中国和美国是主要贡献者.
关键机构包括福丹大学和华中科技大学.
新兴的研究热点包括"免疫向抑制"",瘤微环境"和"免疫疗法".

结论:

这项研究提供了 TIME 在肝癌干预治疗中的第一个全面的图书统计概述.
它为当前的研究趋势提供了宝贵的见解,并确定了有前途的未来研究方向.

关键词:

肝癌是一种肝癌.科学网络 (WOS) 的网站文献计量分析的分析干预性治疗是一种干预性治疗.瘤免疫微环境 (时间)

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.